# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Kaposiform hemangioendothelioma

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-9 of 9 results.
Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma
Status: Recruiting
Last Changed: Oct 03, 2019
First Received: Aug 14, 2019
Disease(s): Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma
Intervention(s): Tacrolimus ointment
Locations: West China Hospital of Sichuan University, Chengdu, Sichuan, China
Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma
Status: Recruiting
Last Changed: Jul 24, 2020
First Received: Jun 26, 2020
Disease(s): Kaposiform Hemangioendothelioma, Kasabach-Merritt Syndrome
Intervention(s): Sirolimus
Locations: Children's Hospital of Fudan University, Shanghai, Shanghai, China
Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma
Status: Recruiting
Last Changed: Sep 04, 2019
First Received: Sep 04, 2019
Disease(s): Hemangioma, Kaposiform Hemangioendothelioma
Intervention(s): Sirolimus(0.8mg/m2), Sirolimus(0.7mg/m2)
Locations: Children's Hospital of Fudan University, Shanghai, China
Sirolimus Plus Propranolol Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma
Status: Recruiting
Last Changed: Apr 14, 2020
First Received: Jun 15, 2017
Disease(s): Kaposiform Hemangioendothelioma, Kasabach Merritt Phenomenon
Intervention(s): Sirolimus, Prednisolone, Propranolol
Locations: West China Hospital of Sichuan University, Chengdu, Sichuan, China
SCMC Trial on KHE With KMP (V.2020)
Status: Not yet recruiting
Last Changed: Jun 09, 2020
First Received: Jun 01, 2020
Disease(s): Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP)
Intervention(s): prednison and Sirolimus, prednison
Locations: Shanghai Children's Medical Center Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China
A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors
Status: Active, not recruiting
Last Changed: Mar 02, 2020
First Received: Apr 10, 2014
Disease(s): Kaposiform Hemangioendothelioma (KHE), Kasabach-Merritt Syndrome, Tufted Angioma
Intervention(s): Vincristine, Sirolimus
Locations: Lucille Packard Children's Hospital Stanford, Palo Alto, California, United States
Emory Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Johns Hopkins, Baltimore, Maryland, United States
Boston Children's Hospital, Boston, Massachusetts, United States
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
... and 3 other locations.
Identification of Biomarkers for Patients With Vascular Anomalies
Status: Recruiting
Last Changed: Feb 05, 2020
First Received: Dec 22, 2016
Disease(s): Vascular Anomaly, Generalized Lymphatic Anomaly, Kaposiform Hemangioendothelioma, Kaposiform Lymphangiomatosis, Gorham-Stout Disease, Klippel Trenaunay Syndrome, Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi
Locations: Boston Children's Hospital, Boston, Massachusetts, United States
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
Status: Unknown status
Last Changed: Feb 05, 2015
First Received: Sep 11, 2009
Disease(s): Kaposiform Hemangioendotheliomas, Tufted Angioma, Capillary Venous Lymphatic Malformation, Venous Lymphatic Malformation, Microcystic Lymphatic Malformation, Mucocutaneous Lymphangiomatosis and Thrombocytopenia, Capillary Lymphatic Arterial Venous Malformations, PTEN Overgrowth Syndrome With Vascular Anomaly, Lymphangiectasia Syndromes
Intervention(s): sirolimus
Locations: Children's Hospital Boston, Boston, Massachusetts, United States
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Lymphatic Anomalies Registry for the Assessment of Outcome Data
Status: Recruiting
Last Changed: Mar 04, 2020
First Received: Mar 26, 2015
Disease(s): Lymphatic Malformation, Generalized Lymphatic Anomaly (GLA), Central Conducting Lymphatic Anomaly, CLOVES Syndrome, Gorham-Stout Disease ("Disappearing Bone Disease"), Blue Rubber Bleb Nevus Syndrome, Kaposiform Lymphangiomatosis, Kaposiform Hemangioendothelioma/Tufted Angioma, Klippel-Trenaunay Syndrome, Lymphangiomatosis
Locations: Boston Children's Hospital, Boston, Massachusetts, United States